The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Cancer Admission Score Prediction Model.
- Who it may be relevant to
- Registry conditions: Oncology. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Netherlands
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Internal Prospective validatiON of a prediCtiOn Model for the Change of admIssion for Patient With caNcer Admitted to the emerGency Department (ONCOMING Study)
Overview
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.
Detailed description
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process.
The first part of this study is an observational part. For patients with cancer that are presented to the emergency department (ED) the cancer admission score (CAS) will be calculated by the model both after triage and after the first blood results are in. Furthermore, the expected disposition will be asked to the attending nurse after triage and after the first blood results. Finally, the actual disposition will be written down after the patient has left the ED, in combination with ED length of stay (LOS) and the time for the attending physician to reach a decision about the disposition (time-to-disposition) and the time for a patient to leave the ED (time-to-leave).
The second part is the interventional part. In this part we introduce an early bed reservation intervention. The CAS is still calculated for the patient. If the CAS is 80% or higher based on the triage, the attending physician will be alerted and a call to the bed coordinator will be placed to reserve a bed in advance. After the first blood results are known the second CAS will be calculated, if this drops below 70% the reserved bed can be canceled by the attending physician. Similar to the first part, the expected disposition from the attending nurse after triage and after first blood results will be collected. Finally, the actual disposition, ED LOS, time-to-disposition and time-to-leave will be noted.
Interventions
- Other Cancer Admission Score Prediction Model
A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results
Primary outcome measures
- Cancer Admission Score [Time frame: Through study completion, an average of 6 months]
- Disposition [Time frame: Through study completion, an average of 6 months]
- Agreement between the CAS and the actual disposition [Time frame: Through study completion, an average of 6 months]
Secondary outcome measures (4)
- Agreement between expected disposition by nurse and actual disposition [Time frame: Through study completion, an average of 6 months]
- time-to-disposition [Time frame: Through study completion, an average of 6 months]
- time-to-leave [Time frame: Through study completion, an average of 6 months]
- ED Length of Stay [Time frame: Through study completion, an average of 6 months]
Eligibility criteria
Inclusion criteria
- Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.
Exclusion criteria
- <18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Netherlands · 1 center
- Erasmus University Medical Center — Rotterdam
Identifiers
NCT: NCT06558487 · 12821